Reyvow
NDC 0002-4312, lasmiditan, tablet, from Eli Lilly and Company.
- Product NDC
- 0002-4312
- Status
- Listed
- Labeler
- Eli Lilly and Company
- Dosage form
- TABLET
- Route
- ORAL
- Product type
- HUMAN PRESCRIPTION DRUG
- Marketing category
- NDA
- Application
- NDA211280
- DEA schedule
- CV
curl https://api.healthcare.dev/v1/drugs/ndc/0002-4312 \ -H "Authorization: Bearer $HDEV_API_KEY"
Product
Active ingredients and packages
Active ingredients
- LASMIDITAN50 mg/1
| Package NDC | NDC-11 | Package |
|---|---|---|
| 0002-4312-08 | 00002431208 | 2 BLISTER PACK in 1 CARTON (0002-4312-08) / 4 TABLET in 1 BLISTER PACK |
Linked data
RxNorm, label and prices
RxNorm concepts
Related lookups
FDA label sections
GET /v1/drugs/labels/aea3358c-ff41-4490-9e6d-c7bf7b3de13fNADAC price for package 00002431208
GET /v1/drugs/nadac/00002431208
Use it
Look up 0002-4312 from code or an agent
curl https://api.healthcare.dev/v1/drugs/ndc/0002-4312 \ -H "Authorization: Bearer $HDEV_API_KEY"
Using the healthcare.dev MCP server, look up NDC 0002-4312. Tell me the product, its labeler, dosage form and route, its packages, and the RxNorm concepts it maps to.
Source: FDA, release 2026-10-23. Public domain. Reference data, not medical advice.